Provided by Tiger Trade Technology Pte. Ltd.

ProShares Pet Care ETF

46.76
+0.32960.71%
Post-market: 46.880.1204+0.26%19:30 EDT
Volume:362
Turnover:16.96K
Market Cap:30.39M
PE:- -
High:46.88
Open:46.88
Low:46.76
Close:46.43
52wk High:57.44
52wk Low:45.96
Shares:650.00K
Float Shares:650.00K
Volume Ratio:0.18
T/O Rate:0.06%
Dividend:0.36
Dividend Rate:0.77%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Options Volatility and Implied Earnings Moves This Week, September 08 – September 11, 2026

TIPRANKS
·
Sep 07

Merck & Co. Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 05

Chewy Seen with Solid 2Q Setup After Guidance Cut

Dow Jones
·
Sep 05

Chewy Price Target Cut to $32.00/Share from $40.00 by Mizuho

Dow Jones
·
Sep 05

Wall Street Analysts Are Bullish on Top Consumer Cyclical Picks

TIPRANKS
·
Sep 04

Merck Price Target Raised to $170.00/Share from $150.00 by Wells Fargo

Dow Jones
·
Sep 04

Dow Jones Top Company Headlines at 9 am ET: EQT to Buy Insurance Broker McGill in $2 Billion Deal | Tesla-Challenging ...

Dow Jones
·
Sep 04

Chewy price target lowered to $32 from $40 at Mizuho

TIPRANKS
·
Sep 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Sep 04

Wells Fargo Adjusts Price Target on Merck & Co. to $170 From $150, Keeps Overweight Rating

MT Newswires Live
·
Sep 04

Eisai’s Lenvima Combo Trial in Liver Cancer Ends With Mixed but Market-Relevant Results

TIPRANKS
·
Sep 04

Summit Therapeutics Says it is Beating Merck with Its Cancer Drug

Dow Jones
·
Sep 04

Zoetis Declares Q3 2026 Dividend of R$ 0.11 Per Unit

Reuters
·
Sep 03

Jefferies Reaffirms Their Hold Rating on Merck KGaA (0O14)

TIPRANKS
·
Sep 03

Revvity Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Zoetis Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Sep 03

Chewy's Fiscal Q2 Results to Test Credibility of H2 Outlook, UBS Securities Says

MT Newswires Live
·
Sep 03

Freshpet (FRPT) Is Getting Attention, So What Are Investors Weighing?

Simply Wall St.
·
Sep 02

Novartis Signs Deal Worth up to $3.2 Billion for Alteogen's Drug Delivery Technology

Reuters
·
Sep 02

Zoetis CEO Peck, CFO Saccaro to Speak at Morgan Stanley Global Healthcare Conference

Reuters
·
Sep 02